Abstract
The discovery and characterization of two classes of kappa opioid receptor agonists that are biased for G protein over βarrestin signaling are described.
Funding Information
  • National Human Genome Research Institute (5U54HG005031, 5U54HG005033)
  • National Institute on Drug Abuse (1X01DA026208, 5R01DA031927, 5U01DA022950)
  • National Institute of Mental Health (HHSN-271-2008-00025-C)
  • National Institute of General Medical Sciences (5P50GM069663)

This publication has 47 references indexed in Scilit: